↓ Skip to main content

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Overview of attention for article published in Annals of Oncology, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy
2 policy sources
twitter
3 tweeters
facebook
3 Facebook pages

Citations

dimensions_citation
986 Dimensions

Readers on

mendeley
767 Mendeley
Title
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Published in
Annals of Oncology, October 2012
DOI 10.1093/annonc/mds236
Pubmed ID
Authors

H.J. Schmoll, E. Van Cutsem, A. Stein, V. Valentini, B. Glimelius, K. Haustermans, B. Nordlinger, C.J. van de Velde, J. Balmana, J. Regula, I.D. Nagtegaal, R.G. Beets-Tan, D. Arnold, F. Ciardiello, P. Hoff, D. Kerr, C.H. Köhne, R. Labianca, T. Price, W. Scheithauer, A. Sobrero, J. Tabernero, D. Aderka, S. Barroso, G. Bodoky, J.Y. Douillard, H. El Ghazaly, J. Gallardo, A. Garin, R. Glynne-Jones, K. Jordan, A. Meshcheryakov, D. Papamichail, P. Pfeiffer, I. Souglakos, S. Turhal, A. Cervantes

Abstract

Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 767 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 6 <1%
United Kingdom 3 <1%
Belgium 3 <1%
Denmark 2 <1%
Brazil 2 <1%
Ecuador 2 <1%
Portugal 1 <1%
Morocco 1 <1%
Malaysia 1 <1%
Other 7 <1%
Unknown 739 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 124 16%
Other 99 13%
Student > Ph. D. Student 93 12%
Student > Master 85 11%
Student > Bachelor 78 10%
Other 194 25%
Unknown 94 12%
Readers by discipline Count As %
Medicine and Dentistry 428 56%
Agricultural and Biological Sciences 60 8%
Biochemistry, Genetics and Molecular Biology 48 6%
Pharmacology, Toxicology and Pharmaceutical Science 21 3%
Nursing and Health Professions 18 2%
Other 73 10%
Unknown 119 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2016.
All research outputs
#2,984,561
of 18,097,951 outputs
Outputs from Annals of Oncology
#1,666
of 6,699 outputs
Outputs of similar age
#21,995
of 144,209 outputs
Outputs of similar age from Annals of Oncology
#27
of 128 outputs
Altmetric has tracked 18,097,951 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,699 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.5. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,209 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.